Continuous renal replacement therapy (CRRT) was used more frequently in MASLD patients (OR 2.5, 95% 0.63–9.3), though this did not reach statistical significance.
← all excerpts
Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes a Distinct Semaphorin-Cytokine Immune Signature in Severe Community-Acquired Pneumonia.
1
—
—